Drug Type Antibody fusion proteins |
Synonyms FPE 022, FPE022 |
Target |
Action modulators |
Mechanism IL-10 modulators(Interleukin-10 modulators), VEGI modulators(Tumor necrosis factor superfamily member 15 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | China | 15 Jun 2024 | |
Inflammatory Bowel Diseases | Discovery | China | 01 May 2025 |